AstraZeneca (AZN) – Management Comments
-
Astra (AZN) Aims For Low-cost Obesity Pill To Sell Worldwide: CEO - Bloomberg
-
FibroGen (FGEN) announces FDA will hold an advisory committee meeting to review the new drug application for roxadustat
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to AZN Stock Lookup